Topic
31 stories from Planck Standard. Latest: October 31, 2026.
Sixteen more users were seriously injured. The Illinois supplier tells customers to stop using the beds unless modified, but says they can still be used per its instructions.
Health Secretary Robert F. Kennedy Jr., who says he has used some of the compounds, is using "enforcement discretion" instead of rulemaking. Consumer groups warn it puts patients at risk.
The cases, obtained by CBS News under FOIA, appear to be the first public U.S. accounts linking illicit retatrutide to a death, though the details are unverified.
The agency told a federal court it expects to finish its mifepristone study by mid-December and report no later than March 2027, before deciding on any new restrictions.
Dr. Heidi Overton called the MMR vaccine and the abortion pill mifepristone safe and effective under FDA review, but dodged questions about IUDs and whether she would stand up to the president.
The panel voted 7-2 that the benefits of Grail's Galleri test outweigh its risks, but only 6-4 that it works. A top National Cancer Institute scientist warned that a broad rollout would "risk harm and waste resources."
Updated vaccines from Moderna, Pfizer and Sanofi target the XFG variant behind roughly 40% of U.S. cases. Who has to pay for them is the part nobody can answer.
A Minneapolis grower recalled its five-ounce containers after federal health officials tied a rare double outbreak to a single farm. Illnesses began May 31.
The Juul2 pairs with an app that requires proof of being 21 before the device will work. The agency was careful to say the authorization is not an endorsement.
Moderna's mFlusiva beat a standard flu shot by 26.6% in a 40,805-person trial. Against hospitalizations and ER visits, the gap was 47.9%.
Indiana-based Midwest Poultry Services recalled roughly 1.6 million dozen shell eggs sold at Kroger and Brookshire stores. Twenty-six people have been hospitalized since November.
Federal health officials say shredded iceberg lettuce from Taylor Farms de Mexico is the likely source of a parasite outbreak that has hospitalized 94 people, even after one lab test came back a false positive.
The broad-spectrum filter, a staple in Europe for years, gives U.S. consumers stronger protection against the UVA rays tied to aging and skin cancer. Products are expected this fall.
Federal investigators traced shredded iceberg lettuce served at Taco Bell in five states to the California grower, in what is now the worst year on record for cyclosporiasis in the United States.
Phase 3 results showed young children with sickle cell disease or beta thalassemia became free of pain crises or transfusions after a single treatment that rewrites their own blood cells.
Biotech company plans new application following FDA leadership changes, after previously criticizing agency for inconsistent guidance around trials.
Senior Trump-era appointees told FDA scientists their findings had 'messaging concerns,' even as Judge Sara Ellis's March 16 order restoring the old ACIP charter heads to the Seventh Circuit.
Dr. Tracy Beth Hoeg dismissed without explanation as federal health agency faces mounting challenges and leadership questions.
Justices reject appeals court ruling that would have restricted mifepristone distribution while litigation continues.
Makary's brief tenure marked by internal dysfunction and mounting criticism from drugmakers and physicians over regulatory decisions.
Reports suggest the president intends to remove the FDA chief in a move that could significantly reshape federal health policy and drug regulation.
Government blocked publication of research conflicting with RFK Jr.'s anti-vaccine positions as health policy becomes increasingly politicized.
Agency's scientists reviewed millions of patient records for vaccine safety studies that were pulled back before release to the public.
High court intervenes after lower court reinstated FDA requirement for in-person visits to obtain medication abortion drug.
Federal appeals court decision overturns FDA regulation allowing mifepristone to be sent to patients, forcing in-person clinic visits nationwide.
Federal appeals court temporarily halted FDA regulation that greatly expanded access to mifepristone through postal delivery.
Louisiana lawsuit leads to emergency halt of FDA regulation that expanded mifepristone distribution nationwide.
Jean Bennett, Albert Maguire, and Katherine High accepted the million prize for work that restored sight to patients with RPE65 mutations and opened the modern era of genetic medicine.
The president's order aims to accelerate research into compounds like psilocybin and ibogaine for treating severe depression and PTSD.
Orforglipron delivered 12.4% average body weight loss in trials and was approved in just 50 days — the fastest new drug approval since 2002 — at per month.
The infant who received a custom-designed gene therapy built specifically for his unique genetic mutation marks his one-year anniversary walking, talking, and helping usher in a new FDA framework for individualized medicine.